Key result
Higher post-PCI hs-CRP linked to ~43% greater risk of major events per doubling.
Why the study?
In stable coronary artery disease, it was unclear whether post-procedural inflammation provides prognostic information distinct from baseline inflammatory status and post-procedural renal function.
Does post-procedural hs-CRP elevation predict adverse cardiovascular outcomes independently of baseline inflammatory status and post-procedural renal function in patients with stable CAD undergoing elective PCI?
Cohort (n=496)
No
Does post-procedural hs-CRP elevation predict adverse cardiovascular outcomes independently of baseline inflammatory status and post-procedural renal function in patients with stable CAD undergoing elective PCI?
Hazard Ratio: 1.43 (95% CI 1.05–1.96)
p-value: p=0.025
In patients with stable CAD undergoing elective PCI, post-procedural hs-CRP and creatinine levels provide independent prognostic information for adverse cardiovascular events beyond baseline inflammatory status.
Post-PCI hs-CRP may refine risk stratification beyond baseline inflammation in elective PCI; leaves open whether serial monitoring or anti-inflammatory interventions alter outcomes.
Background/Objectives: Inflammation contributes to atherosclerotic progression and may intensify after percutaneous coronary intervention (PCI). In stable coronary artery disease (CAD), whether post-procedural inflammation is prognostically distinct from baseline inflammatory status and post-procedural renal function remains unclear. Methods: We studied 496 consecutive patients with stable CAD undergoing elective PCI. The primary outcome was a composite of death, myocardial infarction, stroke, or repeat revascularization. Post-PCI high-sensitivity C-reactive protein (hs-CRP) and creatinine were measured 18–24 h after PCI. Multivariable Cox models used clinically prespecified covariates, with hs-CRP log-transformed (hazard ratio [HR] per doubling) and additionally adjusted for its pre-PCI level; discrimination was assessed by ROC analysis with bootstrap internal validation. Results: The endpoint occurred in 43 patients (8.7%) over a median follow-up of 10 months. Post-PCI hs-CRP was independently associated with the endpoint after adjustment for pre-PCI hs-CRP, post-PCI creatinine, and albumin (HR 1.43 per doubling, 95% CI 1.05–1.96, p = 0.025), and after further adjustment for angiographic and procedural characteristics (HR 1.54, p = 0.008); pre-PCI hs-CRP was not independent (p = 0.083). Post-PCI creatinine was independently associated in every model (HR 1.16 per 0.1 mg/dL, p = 0.001) and identified a largely non-overlapping high-risk group. Conclusions: After elective PCI in stable CAD, post-PCI hs-CRP was independently associated with adverse outcomes and provided prognostic information beyond baseline hs-CRP and procedural characteristics in the fitted models, rather than merely reflecting baseline inflammatory status. Post-PCI renal function was a complementary, largely independent risk signal.
No takes yet. Share an insight, caveat, or question.
Dalgıç et al. (2026) conducted a cohort in Stable coronary artery disease (n=496). Post-PCI high-sensitivity C-reactive protein (hs-CRP) vs. Baseline (pre-PCI) hs-CRP / lower post-PCI hs-CRP was evaluated on Composite of death, myocardial infarction, stroke, or repeat revascularization (HR 1.43, 95% CI 1.05-1.96, p=0.025). Post-PCI hs-CRP was independently associated with a composite of death, myocardial infarction, stroke, or repeat revascularization (HR 1.43 per doubling) beyond baseline inflammatory status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: